Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002852 · ClinicalTrials.gov registry record · Phase 3
Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
A Phase 3 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
NCT00002852: Completed Phase 3 study, sponsored by National Cancer Institute (NCI).
NCT00002852 is a Phase 3 study that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002852, a Phase 3 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
Study Summary
Randomized phase III trial to compare the effectiveness of surgery with or without combination chemotherapy in treating patients who have stage I non-small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known whether surgery is more effective with or without chemotherapy for non-small cell lung cancer.
Interventions
- DRUG carboplatin
- DRUG paclitaxel
- PROCEDURE therapeutic conventional surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 1996-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002852
The ClinicalTrials.gov registry entry for NCT00002852 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which carboplatin is the first listed.
NCT00002852 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002852 about?
NCT00002852 is a clinical study titled "Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer". Randomized phase III trial to compare the effectiveness of surgery with or without combination chemotherapy in treating patients who have stage I non-small cell lung cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more th...
What is the current status of trial NCT00002852?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 1996-10.
What interventions are being tested in trial NCT00002852?
The interventions under investigation include: carboplatin (DRUG), paclitaxel (DRUG), therapeutic conventional surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00002852?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.